Skip to content
Wednesday, November 11, 2026
Scope Current UK

The Zimbabwean Government Rejects ‘One-Sided’ American Healthcare Assistance Agreement Due to Information Fears

Health aid illustration
The offered American funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has turned down a major US health deal valued at $367m (£272m) spanning five years because of Washington's demand for confidential biological samples.

This move came to light following a government memo from December was disclosed, revealing that President Emmerson Mnangagwa deemed the deal was "lopsided".

An official spokesman later explained that the United States was demanding access to genetic material for scientific study and profit but refused to share the resulting advantages from future medical innovations.

"We will now turn to the difficult and regrettable task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has urged more talks to reach a deal acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.

Wider Context

This rejection follows a comparable situation in Kenya, where a court suspended a related health funding agreement following legal challenges were raised about the safety of Kenyans' health data.

After returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

The agency had administered assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance openness and accountability.

As per reports, 16 African countries have so far agreed to these new agreements, constituting more than $18.3bn in committed funds.

Details of the Rejected Agreement

The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to provide its biological resources and data for a long time, with no corresponding guarantee of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.

"In essence, our nation would supply the raw materials for medical research with no assurance that the end products would be available to our people if a new pandemic emerge."

Sovereignty and International Frameworks

Mangwana further noted that the American exit from the global health body and its push of one-on-one health agreements were undermining frameworks already established via the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage future pandemics.

"This mechanism is intended to ensure that when a nation contributes its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," he added.

"We welcome continued dialogue with our American counterparts on how future collaboration could be arranged in a way that respects the independence and dignity of each country."

Medical Community Reaction

A leading public health body expressed it understood the official position, but urged that talks must proceed considering much of the nation's HIV programmes relied on international support.

"Where specific concerns arise, including those relating to information security or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," it added.

This impasse emphasises the ongoing tensions between receiving much-needed foreign assistance and protecting national sovereignty in an increasingly interconnected world.

The writer

Casey Bartlett

Elara Vance is a tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on society.

Scope Current UK

Type to search articles.